top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
In Silico Strategies for Prospective Drug Repositionings
In Silico Strategies for Prospective Drug Repositionings
Autore Udrescu Lucreția
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (288 p.)
Soggetto topico Medicine
Pharmaceutical industries
Soggetto non controllato COVID-19
drug repurposing
topological data analysis
persistent Betti function
SARS-CoV-2
network-based pharmacology
combination therapy
nucleoside GS-441524
fluoxetine
synergy
antidepressant
natural compounds
QSAR
molecular docking
drug repositioning
UK Biobank
vaccine
LC-2/ad cell line
drug discovery
docking
MM-GBSA calculation
molecular dynamics
cytotoxicity assay
GWAS
multiple sclerosis
oxidative stress
repurposing
ADME-Tox
bioinformatics
complex network analysis
modularity clustering
ATC code
hidradenitis suppurativa
acne inversa
transcriptome
proteome
comorbid disorder
biomarker
signaling pathway
druggable gene
drug-repositioning
MEK inhibitor
MM/GBSA
Glide docking
MD simulation
MM/PBSA
single-cell RNA sequencing
pulmonary fibrosis
biological networks
p38α MAPK
allosteric inhibitors
in silico screening
computer-aided drug discovery
network analysis
psychiatric disorders
medications
psychiatry
mental disorders
toxoplasmosis
Toxoplasma gondii
in vitro screening
drug targets
drug-disease interaction
target-disease interaction
DPP4 inhibitors
lipid rafts
ISBN 3-0365-6133-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910639987703321
Udrescu Lucreția  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Molecular Modeling in Drug Design
Molecular Modeling in Drug Design
Autore Wade Rebecca
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 online resource (220 p.)
Soggetto topico Chemistry
Soggetto non controllato adenosine
adenosine receptor
adenosine receptors
adhesion
aggregation
all-atom molecular dynamics simulation
allosterism
Alzheimer's disease
amyloid fibrils
AR ligands
artificial intelligence
AutoGrid
binding affinity
biophenols
boron cluster
cosolvent molecular dynamics
de novo design
deep learning
density-based clustering
docking
drug design
drug discovery
dynamic light scattering
enzymatic assays
EphA2-ephrin A1
extracellular loops
FimH
fragment screening
grid maps
human ecto-5?-nucleotidase
hyperlipidemia
in silico screening
interaction energy
ligand binding
ligand-protofiber interactions
mechanical stability
metadynamics
method development
molecular docking
molecular dynamics
molecular dynamics simulation
molecular modeling
molecular recognition
natural compounds
neural networks
PPI inhibition
probe energies
promiscuous mechanism
property prediction
protein protein interactions
protein-peptide interactions
proteins
quantitative structure-activity relationship (QSAR)
quantitative structure-property prediction (QSPR)
rational drug design
resultant dipole moment
scoring function
solvent effect
squalene synthase (SQS)
steered molecular dynamics
structure-based drug design
target-focused pharmacophore modeling
Traditional Chinese Medicine
turbidimetry
virtual screening
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346839403321
Wade Rebecca  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui